M&A Deal Summary

Devyser Acquires SmartSeq

On February 7, 2022, Devyser acquired information technology company SmartSeq

Acquisition Highlights
  • This is Devyser’s 1st transaction in the Information Technology sector.
  • This is Devyser’s 1st transaction in Italy.

M&A Deal Summary

Date 2022-02-07
Target SmartSeq
Sector Information Technology
Buyer(s) Devyser
Deal Type Add-on Acquisition

Target

SmartSeq

Novara, Italy
SmartSeq provides an integrated analysis of NGS data and develops tools for the analysis, visualization, and exploration of data. The company offers a complete service of custom bioinformatics analysis, database customization and implementation, wet and dry support for RNASeq, metagenomics, and SNPs identification. It offers customers both in-house and outsourced NGS sequencing services. SmartSeq is based in Novara, Italy.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Devyser

Hägersten, Sweden

Category Company
Founded 2004
Sector Manufacturing
Employees120
Revenue 217M SEK (2024)
DESCRIPTION

Devyser specializes in the development, manufacture, and sales of diagnostic kits. Devyser's products are sold to routine diagnostic laboratories in more than 45 countries. The products are used for complex DNA testing within hereditary diseases, oncology, and transplantation. These are used to guide targeted cancer therapies, to enable a wide array of genetic tests, as well as in post-transplant follow-up. Devyser's product development focuses on simplifying and streamlining complex testing processes to improve throughput, reduce hands-on time and produce accurate and trusted results. Devyser was founded in 2004 and is based in Hägersten, Sweden.


DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2022 M&A 1 of 1